Erratum
After publication of [1] it came to the authors’ attention that in the abstract. The sentence “In the present study, we show that S100A7 significantly downregulates the expression of miR-29b in Estrogen Receptor (ER)-positive breast cancer cells (represented by MCF7), and significantly upregulates miR-29b in ER-negative cells (represented by MDA-MB-231)”. Was Incorrect, the correct statement is “In the present study, we show that S100A7 significantly upregulates the expression of miR-29b in Estrogen Receptor (ER)-positive breast cancer cells (represented by MCF7), and significantly downregulates miR-29b in ER-negative cells (represented by MDA-MB-231)”.
Footnotes
The online version of the original article can be found under doi:10.1186/s12943-014-0275-z.
Contributor Information
Helong Zhao, Email: zhao.364@osu.edu.
Tasha Wilkie, Email: wilkie.20@osu.edu.
Yadwinder Deol, Email: yadwinder.deol@osumc.edu.
Amita Sneh, Email: amita.sneh@osumc.edu.
Akaansha Ganju, Email: akaansha.ganju@osumc.edu.
Mustafa Basree, Email: basree.1@osu.edu.
Mohd W. Nasser, Email: Mohd.Nasser@osumc.edu
Ramesh K. Ganju, Email: Ramesh.Ganju@osumc.edu
Reference
- 1.Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, et al. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Mol Cancer. 2015;14:11. doi: 10.1186/s12943-014-0275-z. [DOI] [PMC free article] [PubMed] [Google Scholar]